CareDx (CDNA) Cash from Financing Activities (2013 - 2026)
CareDx (CDNA) posted Cash from Financing Activities of -$15.5 million for Q2 2026, down 432.39% sequentially from -$2.9 million in Q1 2026, and up 71.2% YoY from -$9.1 million in Q2 2025.
CareDx (CDNA) Cash from Financing Activities (2013 - 2026) Analysis & Trends
CareDx has reported Cash from Financing Activities for 14 years, with the latest figure at -$15.5 million in Q2 2026.
- Quarterly Cash from Financing Activities rose 71.2% year-over-year to -$15.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$57.3 million (down 6.33% YoY) and the FY2025 annual result came in at -$93.4 million, down 1565.97% from the prior year.
- Cash from Financing Activities declined to -$15.5 million in Q2 2026 per CDNA's latest filing, from -$2.9 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $1.4 million in Q3 2024 and troughed at -$53.8 million in Q2 2025.
- A 5-year average of -$8.4 million and a median of -$1.8 million in 2022 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities jumped 5788.0% in 2024, then slumped 1962.03% in 2025.
- Over 5 years, Cash from Financing Activities stood at -$2.4 million in 2022, then sank by 1033.09% to -$26.9 million in 2023, then jumped by 96.64% to -$903000.0 in 2024, then sank by 1280.07% to -$12.5 million in 2025, then retreated by 24.36% to -$15.5 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$15.5 million, -$2.9 million, and -$12.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -325.19 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -144.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -214.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -129.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -317.75 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -229.00 Mn |
| 10 | CareDx | 2.35 Bn | 1.98 Bn | 116.03 Mn | -15.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.50 Mn |
| Jun 30, 2026 | -15.50 Mn |
| Mar 31, 2026 | -2.91 Mn |
| Mar 31, 2026 | -2.91 Mn |
| Dec 31, 2025 | -12.46 Mn |
| Dec 31, 2025 | -12.46 Mn |
| Sep 30, 2025 | -26.48 Mn |
| Sep 30, 2025 | -26.48 Mn |
| Jun 30, 2025 | -53.81 Mn |
| Jun 30, 2025 | -53.81 Mn |
| Mar 31, 2025 | -643,000.00 |
| Mar 31, 2025 | -643,000.00 |
| Dec 31, 2024 | -903,000.00 |
| Dec 31, 2024 | -903,000.00 |
| Sep 30, 2024 | 1.42 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | -4.85 Mn |
| Jun 30, 2024 | -4.85 Mn |
| Mar 31, 2024 | -1.28 Mn |
| Mar 31, 2024 | -1.28 Mn |